AbbVie Inc. (ABBV) stock analysis

In our weekly check, AbbVie Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 6, red flags: 1.

About AbbVie Inc.

AbbVie Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as ABBV.

What our checks show for ABBV

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-03

Similar companies

JNJ · MRK · NVS · AZN · AMGN · GILD

Questions

What grade does AbbVie Inc. (ABBV) have?

In our weekly check, AbbVie Inc. is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 6, red flags: 1. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of ABBV stock?

This week's biggest flags for AbbVie Inc.: Dividend stretched, Margins falling, Weak revenue growth. In total 7 of 25 checks show a warning or a red flag.

What does AbbVie Inc. do?

AbbVie Inc. is a Healthcare company (Drug Manufacturers - General) based in the United States, listed on NYSE as ABBV.

When does AbbVie Inc. report earnings next?

The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis